These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37464836)

  • 21. Quinazoline-4(3
    Turanlı S; Ergül AG; Jordan PM; Olğaç A; Çalışkan B; Werz O; Banoglu E
    ACS Omega; 2022 Oct; 7(41):36354-36365. PubMed ID: 36278102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epoxygenated fatty acids and soluble epoxide hydrolase inhibition: novel mediators of pain reduction.
    Wagner K; Inceoglu B; Gill SS; Hammock BD
    J Agric Food Chem; 2011 Apr; 59(7):2816-24. PubMed ID: 20958046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, Synthesis and Biological Activity of 4,6-disubstituted Pyridin-2(1
    Hejazi L; Rezaee E; Tabatabai SA
    Iran J Pharm Res; 2019; 18(4):1759-1769. PubMed ID: 32184844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel dual-target FAAH and TRPV1 ligands as potential pharmacotherapeutics for pain management.
    Qiao Z; Liu S; Zhai W; Jiang L; Ma Y; Zhang Z; Wang B; Shao J; Qian H; Zhao F; Yan L
    Eur J Med Chem; 2024 Mar; 267():116208. PubMed ID: 38325006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of the binding mode of 1, 3, 4-oxadiazole derivatives as amide-based inhibitors for soluble epoxide hydrolase (sEH) by molecular docking and MM-GBSA.
    Karami L; Saboury AA; Rezaee E; Tabatabai SA
    Eur Biophys J; 2017 Jul; 46(5):445-459. PubMed ID: 27928588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quinazoline-4(3H)-one derivatives as novel and potent inhibitors of soluble epoxide hydrolase: Design, synthesis and biological evaluation.
    Hejazi L; Rezaee E; Tabatabai SA
    Bioorg Chem; 2020 Jun; 99():103736. PubMed ID: 32229350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of memantyl urea derivatives as potent soluble epoxide hydrolase inhibitors against lipopolysaccharide-induced sepsis.
    Du F; Sun W; Morisseau C; Hammock BD; Bao X; Liu Q; Wang C; Zhang T; Yang H; Zhou J; Xiao W; Liu Z; Chen G
    Eur J Med Chem; 2021 Nov; 223():113678. PubMed ID: 34218083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ligand-based optimization to identify novel 2-aminobenzo[d]thiazole derivatives as potent sEH inhibitors with anti-inflammatory effects.
    Han Y; Huang D; Xu S; Li L; Tian Y; Li S; Chen C; Li Y; Sun Y; Hou Y; Sun Y; Qin M; Gong P; Gao Z; Zhao Y
    Eur J Med Chem; 2021 Feb; 212():113028. PubMed ID: 33248848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery and Optimization of Piperazine Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors.
    Çapan İ; Jordan PM; Olğaç A; Çalışkan B; Kretzer C; Werz O; Banoglu E
    ChemMedChem; 2022 Jun; 17(12):e202200137. PubMed ID: 35466565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase.
    Karbarz MJ; Luo L; Chang L; Tham CS; Palmer JA; Wilson SJ; Wennerholm ML; Brown SM; Scott BP; Apodaca RL; Keith JM; Wu J; Breitenbucher JG; Chaplan SR; Webb M
    Anesth Analg; 2009 Jan; 108(1):316-29. PubMed ID: 19095868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (4-Phenoxyphenyl)tetrazolecarboxamides and related compounds as dual inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
    Holtfrerich A; Hanekamp W; Lehr M
    Eur J Med Chem; 2013 May; 63():64-75. PubMed ID: 23455058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of novel drug candidates for inhibition of soluble epoxide hydrolase of arachidonic acid cascade pathway implicated in atherosclerosis.
    Gurung AB; Mayengbam B; Bhattacharjee A
    Comput Biol Chem; 2018 Jun; 74():1-11. PubMed ID: 29522918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design of Dual Inhibitors of Soluble Epoxide Hydrolase and LTA
    Hiesinger K; Schott A; Kramer JS; Blöcher R; Witt F; Wittmann SK; Steinhilber D; Pogoryelov D; Gerstmeier J; Werz O; Proschak E
    ACS Med Chem Lett; 2020 Mar; 11(3):298-302. PubMed ID: 32184960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benzoxazolone-5-Urea Derivatives as Human Soluble Epoxide Hydrolase (sEH) Inhibitors.
    Gur Maz T; Koc B; Jordan PM; İbiş K; Çalışkan B; Werz O; Banoglu E
    ACS Omega; 2023 Jan; 8(2):2445-2454. PubMed ID: 36687110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain.
    Lee KSS; Ng JC; Yang J; Hwang SH; Morisseau C; Wagner K; Hammock BD
    Bioorg Med Chem; 2020 Nov; 28(22):115735. PubMed ID: 33007552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural soluble epoxide hydrolase inhibitors from Inula britanica and their potential interactions with soluble epoxide hydrolase: Insight from inhibition kinetics and molecular dynamics.
    Zhao WY; Yan JJ; Zhang M; Wang C; Feng L; Lv X; Huo XK; Sun CP; Chen LX; Ma XC
    Chem Biol Interact; 2021 Aug; 345():109571. PubMed ID: 34217688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three-dimensional rational approach to the discovery of potent substituted cyclopropyl urea soluble epoxide hydrolase inhibitors.
    Takai K; Chiyo N; Nakajima T; Nariai T; Ishikawa C; Nakatani S; Ikeno A; Yamamoto S; Sone T
    Bioorg Med Chem Lett; 2015 Apr; 25(8):1705-1708. PubMed ID: 25800114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small Molecule Soluble Epoxide Hydrolase Inhibitors in Multitarget and Combination Therapies for Inflammation and Cancer.
    Das Mahapatra A; Choubey R; Datta B
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33255197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 2. Discovery of 7-azaspiro[3.5]nonane urea PF-04862853, an orally efficacious inhibitor of fatty acid amide hydrolase (FAAH) for pain.
    Meyers MJ; Long SA; Pelc MJ; Wang JL; Bowen SJ; Schweitzer BA; Wilcox MV; McDonald J; Smith SE; Foltin S; Rumsey J; Yang YS; Walker MC; Kamtekar S; Beidler D; Thorarensen A
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6545-53. PubMed ID: 21924613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-guided discovery of potent and oral soluble epoxide hydrolase inhibitors for the treatment of neuropathic pain.
    Du F; Cao R; Chen L; Sun J; Shi Y; Fu Y; Hammock BD; Zheng Z; Liu Z; Chen G
    Acta Pharm Sin B; 2022 Mar; 12(3):1377-1389. PubMed ID: 35530144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.